The Journal of Urology
Volume 183, Issue 2 , Pages 455-459, February 2010

Effect of Reclassification on the Incidence of Benign and Malignant Renal Tumors

  • Ted A. Skolarus

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • Corresponding Author InformationCorrespondence: Division of Urologic Surgery, Washington University in St. Louis, 4960 Children's Place, Box 8242, St. Louis, Missouri 63110 (telephone: 314-362-8212)
    • ,
  • Maria F. Serrano

      Affiliations

    • Department of Pathology and Immunology, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Robert L. Grubb III

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with GlaxoSmithKline and the National Cancer Institute–PLCO Cancer Screening Trial.
    • ,
  • Matthew D. Katz

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Travis L. Bullock

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with Astellas.
    • ,
  • Feng Gao

      Affiliations

    • Division of Biostatistics, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Peter A. Humphrey

      Affiliations

    • Department of Pathology and Immunology, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Adam S. Kibel

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with Sanofi-Aventis, Envisioneering Medical Technologies, Wilex, Ortho-McNeil Phramaceutical and AstraZeneca.

Received 10 June 2009 published online 14 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional review board approval.

 Editor's Note: This article is the second of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 834 and 835.

PII: S0022-5347(09)02703-7

doi:10.1016/j.juro.2009.10.045

The Journal of Urology
Volume 183, Issue 2 , Pages 455-459, February 2010

Article Tools

* Image Usage & Resolution